Bellevue Group AG

Q4 2024 13F Holdings Report, Stock Holdings

Signature - Title
Christoph Eisenring / Stefano Montalbano - Head Legal & Compliance / CFO
Location
Kuesnacht, Switzerland
Holdings as of
December 31, 2024
Value $
$5.19B
Num holdings
160
Date filed
2/14/2025, 04:06 PM
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included ARGX, IONS, NBIX, ISRG, and ITCI.
Previous filing
Q3 2024 - Nov 14, 2024
Next filing
Q1 2025 - May 14, 2025
SEC
View on sec.gov
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2024 Q4 compared to 2024 Q3 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Christoph Eisenring / Stefano Montalbano Head Legal & Compliance / CFO Kuesnacht, Switzerland 2/12/2025

Other Included Managers (3):

Num Name Location File Number
1 Bb Biotech Ag Schaffhausen, Switzerland 028-06964
2 Bellevue Asset Management AG Kuesnacht, Switzerland 028-16892
3 Bellevue Asset Management (UK) Ltd. London, United Kingdom 028-20408